Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Garrison

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Family Physician|April 18, 2015
Screening, diagnosis, and management of gestational diabetes mellitusAndrew Garrison
Birth (Berkeley, Calif.)|July 15, 2021
Factors leading to satisfaction with counseling for Labor after Cesarean among Latina women in the United StatesAlyxandra C Williams, Liliana I Martinez, Andrew Garrison, et al.
RMD Open|June 3, 2025
Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular diseaseGerd R Burmester, Eduardo Mysler, Peter Taylor, et al.
RMD Open|January 8, 2026
Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studiesPeter C Taylor, Arthur Kavanaugh, Louis Bessette, et al.
Preventive Medicine|March 17, 2004
Focus groups of Y-K Delta Alaska Natives: attitudes toward tobacco use and tobacco dependence interventionsCaroline C Renner, Christi A Patten, Carrie Enoch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2024
Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction TherapyJean-Frédéric Colombel, Tadakazu Hisamatsu, Raja Atreya, et al.
Inflammatory Bowel Diseases|November 5, 2025
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's DiseaseMarla C Dubinsky, Geert D'Haens, Olivier Dewit, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2024
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic ExposureLaurent Peyrin-Biroulet, Remo Panaccione, Edouard Louis, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Family Physician|April 18, 2015
Screening, diagnosis, and management of gestational diabetes mellitusAndrew Garrison
Birth (Berkeley, Calif.)|July 15, 2021
Factors leading to satisfaction with counseling for Labor after Cesarean among Latina women in the United StatesAlyxandra C Williams, Liliana I Martinez, Andrew Garrison, et al.
RMD Open|June 3, 2025
Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular diseaseGerd R Burmester, Eduardo Mysler, Peter Taylor, et al.
RMD Open|January 8, 2026
Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studiesPeter C Taylor, Arthur Kavanaugh, Louis Bessette, et al.
Preventive Medicine|March 17, 2004
Focus groups of Y-K Delta Alaska Natives: attitudes toward tobacco use and tobacco dependence interventionsCaroline C Renner, Christi A Patten, Carrie Enoch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2024
Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction TherapyJean-Frédéric Colombel, Tadakazu Hisamatsu, Raja Atreya, et al.
Inflammatory Bowel Diseases|November 5, 2025
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's DiseaseMarla C Dubinsky, Geert D'Haens, Olivier Dewit, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2024
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic ExposureLaurent Peyrin-Biroulet, Remo Panaccione, Edouard Louis, et al.
Pageof 1